Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

AC Immune SA has divulged compounds acting as α-synuclein (SNCA) aggregation inhibitors reported to be useful for the treatment of multiple system atrophy (MSA), Parkinson’s dementia, Lewy body ...

A healthy diet can alleviate chronic pain, reduce inflammation, and improve physical function, especially in women.

People with Parkinson’s disease are to benefit from cutting edge AI technology that allows neuroscientists to safely test medication and treatment on a ‘digital twin’ brain, thanks to a £1m funding ...

This report offers insights into recent health news, encompassing advancements in Parkinson's and cancer treatments, ...

CurePSP, Inc. ("CurePSP") and GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ: 082270) have announced the establishment of Korea's ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

AbbVie (NYSE: ABBV) today announced positive topline results from its pivotal Phase 3 TEMPO-2 trial evaluating investigational tavapadon as a flexible-dose monotherapy in early Parkinson's disease.

The fifth edition of the Integrated Maternal and Perinatal Care Guidelines for South Africa, released by the health ...

A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...